Back
Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
RYTM
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Buy
58
RYTM
Rhythm Pharmaceuticals
Last Price:
39.35
Seasonality Move:
12.65%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereRhythm Pharmaceuticals Price Quote
$39.35
Rhythm Pharmaceuticals Key Stats
Buy
58
Rhythm Pharmaceuticals (RYTM)
is a Buy
Day range:
$37.49 - $41.76
52-week range:
$15.50 - $52.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.31
P/B ratio:
14.13%
Volume:
1.2M
Avg. volume:
571.3K
1-year change:
135.77%
Market cap:
$2.4B
Revenue:
$77.4M
EPS:
$-3.2
How Much Does Rhythm Pharmaceuticals Make?
-
How Much Are Rhythm Pharmaceuticals's Sales Annually?
RYTM Revenues are $77.4M -
How Much Profit Does Rhythm Pharmaceuticals's Make A Year?
RYTM net income is -$184.7M
Is Rhythm Pharmaceuticals Growing As A Company?
-
What Is Rhythm Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.76% -
What Is Rhythm Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Rhythm Pharmaceuticals Stock Price Performance
-
Did Rhythm Pharmaceuticals Stock Go Up Last Month?
Rhythm Pharmaceuticals share price went down by -2.94% last month -
Did RYTM's Share Price Rise Over The Last Year?
RYTM share price rose by 135.77% over the past 1 year
What Is Rhythm Pharmaceuticals 52-Week High & Low?
-
What Is Rhythm Pharmaceuticals’s 52-Week High Share Price?
Rhythm Pharmaceuticals has traded as high as $52.57 over the past 52 weeks -
What Is Rhythm Pharmaceuticals’s 52-Week Low Share Price?
Rhythm Pharmaceuticals has traded as low as $15.50 over the past 52 weeks
Rhythm Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Rhythm Pharmaceuticals?
-
How Much Debt Does Rhythm Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Rhythm Pharmaceuticals Have?
Cash and short term investments quarterly total is $275.8M -
What Is Rhythm Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.86
Is Rhythm Pharmaceuticals Cash Flow Positive?
-
What Is RYTM Cash Flow From Operations?
Cash flow from operations (TTM) is -$136.2M -
What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $74.4M -
What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.7M
Rhythm Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
RYTM return on invested capital is -89.34% -
What Is Rhythm Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -53.53% -
What Is RYTM Return On Equity?
ROE is a measure of profitability and is -89.34%
Rhythm Pharmaceuticals Earnings Date & Stock Price
-
What Is Rhythm Pharmaceuticals's Stock Price Today?
A single share of RYTM can be purchased today for 39.35 -
What Is Rhythm Pharmaceuticals’s Stock Symbol?
Rhythm Pharmaceuticals trades on the nasdaq under the ticker symbol: RYTM -
When Is Rhythm Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Rhythm Pharmaceuticals is scheduled on August 1, 2024 -
When Is RYTM's next ex-dividend date?
Rhythm Pharmaceuticals's next ex-dividend date is May 8, 2024 -
How To Buy Rhythm Pharmaceuticals Stock?
You can buy Rhythm Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Rhythm Pharmaceuticals Competitors
-
Who Are Rhythm Pharmaceuticals's Competitors?
Below is a list of companies who compete with Rhythm Pharmaceuticals or are related in some way:
Rhythm Pharmaceuticals Dividend Yield
Data Unavailable
Rhythm Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -5.22% |
Revenue: | 175.7% | -3.46% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 56.89 |
Upside from Last Price: | 44.57% |